BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28077370)

  • 1. Preoperative aqueous humour flare values do not predict proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Mulder VC; Tode J; van Dijk EH; Purtskhvanidze K; Roider J; van Meurs JC; Treumer F
    Br J Ophthalmol; 2017 Sep; 101(9):1285-1289. PubMed ID: 28077370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of aqueous flare measurement in predicting proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Conart JB; Kurun S; Ameloot F; Tréchot F; Leroy B; Berrod JP
    Acta Ophthalmol; 2017 Jun; 95(4):e278-e283. PubMed ID: 27682827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative aqueous humour flare as a surrogate marker for proliferative vitreoretinopathy development.
    Mulder VC; van Dijk EHC; van Meurs IA; La Heij EC; van Meurs JC
    Acta Ophthalmol; 2018 Mar; 96(2):192-196. PubMed ID: 29068530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.
    Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S
    Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Schröder S; Muether PS; Caramoy A; Hahn M; Abdel-Salam M; Diestelhorst M; Kirchhof B; Fauser S
    Retina; 2012 Jan; 32(1):38-42. PubMed ID: 21765375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
    Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
    Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.
    Ichinohasama R; Nishiguchi KM; Fujita K; Aizawa N; Inoue T; Sasaki E; Kunikata H; Nakazawa T
    Curr Eye Res; 2018 Jun; 43(6):804-809. PubMed ID: 29547015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tyndallometry and cell count in the anterior chamber in retinal detachment].
    Amann T; Nguyen NX; Küchle M
    Klin Monbl Augenheilkd; 1997 Jan; 210(1):43-7. PubMed ID: 9206733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Area of Detachment, Proliferative Vitreoretinopathy, and Pulse Pressure, but not AGEs, are Associated With Retinal Redetachment.
    Fokkens BT; Mulder DJ; Nugteren MB; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6633-6638. PubMed ID: 27926755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal Injection of Bevacizumab for the Prevention of Postoperative Proliferative Vitreoretinopathy in High-Risk Patients Selected by Laser Flare Photometry.
    Gahon M; Luc A; Zessler A; Pastor G; Angioi-Duprez K; Thilly N; Berrod JP; Conart JB
    Ophthalmologica; 2023; 246(5-6):306-313. PubMed ID: 37769629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of changes in aqueous flare intensity after vitrectomy for rhegmatogenous retinal detachment.
    Hoshi S; Okamoto F; Hasegawa Y; Sugiura Y; Okamoto Y; Hiraoka T; Oshika T
    Retina; 2012 Oct; 32(9):1862-7. PubMed ID: 22466487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; Kessels AG; de Jager W; Hendrikse F; La Heij EC
    Exp Eye Res; 2012 Jan; 94(1):56-62. PubMed ID: 22138416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.
    Schaub F; Hoerster R; Schiller P; Felsch M; Kraus D; Zarrouk M; Kirchhof B; Fauser S
    Trials; 2018 Jul; 19(1):384. PubMed ID: 30012187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postoperative proliferative vitreoretinopathy in rhegmatogenous retinal detachment associated with stage B preoperative proliferative vitreoretinopathy: comparative results of trans-scleral retinopexy with diode laser or trans-pupillary retinopexy with argon laser].
    Duquesne N; Fleury J; Bonnet M
    J Fr Ophtalmol; 1998 Oct; 21(8):555-9. PubMed ID: 9833220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.
    Yu J; Peng R; Chen H; Cui C; Ba J
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.
    Limb GA; Chignell AH
    Br J Ophthalmol; 1999 Aug; 83(8):953-6. PubMed ID: 10413701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
    Schaub F; Schiller P; Hoerster R; Kraus D; Holz FG; Guthoff R; Agostini H; Spitzer MS; Wiedemann P; Lommatzsch A; Boden KT; Dimopoulos S; Bemme S; Tamm S; Maier M; Roider J; Enders P; Altay L; Fauser S; Kirchhof B;
    Ophthalmology; 2022 Oct; 129(10):1129-1141. PubMed ID: 35680097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laser flare photometry for identification of high-risk patients for proliferative vitreoretinopathy].
    Schaub F; Fauser S; Kirchhof B; Witte A; Hörster R
    Ophthalmologe; 2018 Dec; 115(12):1079-1083. PubMed ID: 30151741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
    Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.